Company news

Inventiva SA news in 2025

Inventiva SA's news releases, calls and decks from 2025, newest first.

View company

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 17, 2025

Results of the Votes of the Combined Shareholders’ General Meeting of November 27, 2025

November 28, 2025

Information relating to the stabilization activities carried out in the context of its recent offering

November 24, 2025

Inventiva reports 2025 Third Quarter Financial Information¹

November 21, 2025

Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M

November 17, 2025

Inventiva announces trading resumption of its ordinary shares on Euronext Paris

November 13, 2025

Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares

November 13, 2025

Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris

November 13, 2025

Inventiva announces launch of public offering

November 12, 2025

Combined General Meeting of November 27, 2025 - Availability of the preparatory documents

November 6, 2025

Inventiva Announces the Implementation of a New ATM Program

October 14, 2025

Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025

October 7, 2025

Inventiva Appoints Andrew Obenshain as Chief Executive Officer

October 1, 2025

Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update

September 29, 2025

Inventiva to Host Analyst and Investor Event on October 8, 2025

September 24, 2025

Inventiva to Participate in Upcoming September Investor Conferences

September 4, 2025

Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference

August 11, 2025

Inventiva Reports Preliminary 2025 First-Half Financial Information¹

July 29, 2025

Inventiva names Jason Campagna as President of R&D and Chief Medical Officer and Martine Zimmermann as Executive Vice President of Regulatory Affairs and Quality Assurance

July 9, 2025

Inventiva receives $10 million milestone payment from CTTQ

July 7, 2025

Inventiva announces the publication in Journal of Hepatology Reports on results of lanifibranor treatment on liver sinusoidal endothelial cells in patients with MASLD/MASH and in preclinical models of the disease

July 2, 2025

Inventiva Announces the Appointment of Renée Aguiar-Lucander to its Board of Directors

June 10, 2025

Inventiva to Participate in the Upcoming Jefferies Global Healthcare Conference and UBS Spring Biotech Conference

May 27, 2025

Inventiva reports 2025 First Quarter Financial Information¹

May 23, 2025

Results of the Votes of the Combined Shareholders’ General Meeting of May 22, 2025

May 23, 2025

Description of the Share Repurchase Program Covered by the Liquidity Agreement with Kepler Chevreux

May 22, 2025

Inventiva secures the €116 million second tranche of its structured financing of up to €348 million

May 5, 2025

Combined General Meeting of May 22, 2025 - Availability of the preparatory documents

April 30, 2025

Decks in 2025